Consistent with the observation from the study in patients with stage I to III breast cancer by Byrnes et al [23], our results studied in all stages including stage IV breast cancer patients demonstrated that eIF4E overexpression is associated with high levels of VEGF and MVD counts. This evidence concerns the gene EIF4E and breast carcinoma.